Nagy Á - Search Results

1

miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.

Lánczky A, Nagy Á, Bottai G, Munkácsy G, Szabó A, Santarpia L, Győrffy B. Lánczky A, et al. Among authors: nagy a. Breast Cancer Res Treat. 2016 Dec;160(3):439-446. doi: 10.1007/s10549-016-4013-7. Epub 2016 Oct 15. Breast Cancer Res Treat. 2016. PMID: 27744485

2

Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients.

Szász AM, Lánczky A, Nagy Á, Förster S, Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A, Győrffy B. Szász AM, et al. Among authors: nagy a. Oncotarget. 2016 Aug 2;7(31):49322-49333. doi: 10.18632/oncotarget.10337. Oncotarget. 2016. PMID: 27384994 Free PMC article.

3

KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer.

Nagy Á, Pongor LS, Szabó A, Santarpia M, Győrffy B. Nagy Á, et al. Int J Cancer. 2017 Feb 15;140(4):930-937. doi: 10.1002/ijc.30509. Epub 2016 Nov 23. Int J Cancer. 2017. PMID: 27859136 Free PMC article.

4

[Internet-based opportunities in breast cancer diagnostics and research].

Nagy Á, Gyõrffy B. Nagy Á, et al. Magy Onkol. 2016 Nov 29;60(4):273-280. Epub 2015 Dec 18. Magy Onkol. 2016. PMID: 27898745 Free article. Review. Hungarian.

5

Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.

Nagy Á, Lánczky A, Menyhárt O, Győrffy B. Nagy Á, et al. Sci Rep. 2018 Jun 15;8(1):9227. doi: 10.1038/s41598-018-27521-y. Sci Rep. 2018. PMID: 29907753 Free PMC article. Review.

6

Author Correction: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.

Nagy Á, Lánczky A, Menyhárt O, Győrffy B. Nagy Á, et al. Sci Rep. 2018 Jul 26;8(1):11515. doi: 10.1038/s41598-018-29514-3. Sci Rep. 2018. PMID: 30046141 Free PMC article.

7

Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma.

Menyhárt O, Nagy Á, Győrffy B. Menyhárt O, et al. Among authors: nagy a. R Soc Open Sci. 2018 Dec 5;5(12):181006. doi: 10.1098/rsos.181006. eCollection 2018 Dec. R Soc Open Sci. 2018. PMID: 30662724 Free PMC article.

8

Elevated HOX gene expression in acute myeloid leukemia is associated with NPM1 mutations and poor survival.

Nagy Á, Ősz Á, Budczies J, Krizsán S, Szombath G, Demeter J, Bödör C, Győrffy B. Nagy Á, et al. J Adv Res. 2019 Jun 11;20:105-116. doi: 10.1016/j.jare.2019.05.006. eCollection 2019 Nov. J Adv Res. 2019. PMID: 31333881 Free PMC article.

9

Genomic Mapping Identifies Mutations in RYR2 and AHNAK as Associated with Favorable Outcome in Basal-Like Breast Tumors Expressing PD1/PD-L1.

Cimas FJ, Manzano A, Baliu-Piqué M, García-Gil E, Pérez-Segura P, Nagy Á, Pandiella A, Győrffy B, Ocana A. Cimas FJ, et al. Among authors: nagy a. Cancers (Basel). 2020 Aug 11;12(8):2243. doi: 10.3390/cancers12082243. Cancers (Basel). 2020. PMID: 32796628 Free PMC article.

10

muTarget: A platform linking gene expression changes and mutation status in solid tumors.

Nagy Á, Győrffy B. Nagy Á, et al. Int J Cancer. 2021 Jan 15;148(2):502-511. doi: 10.1002/ijc.33283. Epub 2020 Sep 17. Int J Cancer. 2021. PMID: 32875562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,176 results

Search Page

Filters